The IO Movement: Priming the Immune System to Fight Cancer – Part I: Chimeric Antigen Receptor T (CAR-T) Cell … – Lexology
Lexology |
The IO Movement: Priming the Immune System to Fight Cancer – Part I: Chimeric Antigen Receptor T (CAR–T) Cell …
Lexology This is the first article in a Series focused on current trends in immuno-oncology (I-O) and immunotherapy. Since the latter are becoming household terminology, the goal of this Series is to highlight the value of intellectual property for new … |
